We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BLAU3 market cap is 1.89B. The company's latest EPS is BRL 1.3925 and P/E is 7.56.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 361.63M | 366.7M | 258.2M | 364.31M | 439.84M |
Operating Income | 113.09M | 113.66M | 51.28M | 76M | 152.37M |
Net Income | 94.53M | 94.98M | 51.95M | 70.79M | 99.4M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 977.69M | 1.18B | 1.37B | 1.41B | 1.49B |
Operating Income | 301.48M | 389.13M | 456.62M | 452.19M | 329.44M |
Net Income | 200.24M | 254.33M | 323.86M | 363.37M | 249.81M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 2.44B | 2.5B | 2.51B | 2.5B | 3.07B |
Total Liabilities | 682.62M | 681.11M | 671.83M | 630.16M | 1.1B |
Total Equity | 1.76B | 1.82B | 1.83B | 1.87B | 1.97B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 738.44M | 1.27B | 2.33B | 2.5B | 3.05B |
Total Liabilities | 472.69M | 1.05B | 693.16M | 681.11M | 1.06B |
Total Equity | 265.76M | 221.34M | 1.63B | 1.82B | 2B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 141.75M | 171.9M | 34.73M | 161.51M | 222.59M |
Investing | 62.27M | 132.96M | -5.38M | 62.3M | -399.8M |
Financing | -246.71M | -342.62M | -19.69M | -140.42M | 193.44M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 221.29M | 226.52M | 153.98M | 171.9M | 220.56M |
Investing | -197.41M | -220.78M | -870.32M | 132.96M | -356.81M |
Financing | -75.71M | 57.26M | 698.01M | -342.62M | 153.63M |
Market Cap | 1.89B |
Price to Earnings Ratio | 7.56 |
Price to Sales Ratio | 1.27 |
Price to Cash Ratio | 59.97 |
Price to Book Ratio | 0.95 |
Dividend Yield | 1.78% |
Shares Outstanding | 179.39M |
Average Volume (1 week) | 635.93k |
Average Volume (1 Month) | 371.65k |
52 Week Change | -43.90% |
52 Week High | 22.56 |
52 Week Low | 9.29 |
Spread (Intraday) | 0.37 (3.42%) |
Company Name | Blau Farmaceutica SA |
Address |
rodovia raposo tavares edificio 100 n. 5 2833 cotia, sao paulo |
Website | https://www.blau.com.br |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions